Enzo Biochem Inc. ($0.01 Par Value) (ENZ) Key Ratios
$0.54
As on 18-Jun-2025 09:30EDT
Market cap
$16 Mln
Revenue (TTM)
$27 Mln
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
125 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -12.71 | -20.19 | -50.44 | -37.33 | -18.71 |
| EBIT | -111.55 | -150.85 | -17.34 | 9.40 | 11.18 |
| Net Profit | -81.76 | 7.62 | -377.72 | 4.03 | 7.73 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Jul-24 | Jul-23 |
| EBIT-Margin
| -40.95 | -32.44 | -29.39 | -30.15 | -76.05 |
| Net Margin
| -21.75 | -32.76 | -76.73 | -- | -- |
| Return on equity
| -14.98 | -17.29 | -46.31 | -38.76 | 30.53 |
| Return on Capital
| -12.61 | -14.25 | -- | -35.95 | 25.28 |
| Return on Assets
| -9.34 | -11.19 | -21.55 | -25.12 | 18.64 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.06 | 0.09 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
--
|
-35.95
|
25.28
|
-27.15
|
3.75
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-46.31
Lower than Peers by 54.26
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-46.31
|
-38.76
|
30.53
|
-36.70
|
5.40
|
|
Peer Median
|
7.96
|
--
|
--
|
--
|
--
|
ROA
-21.55
Lower than Peers by 23.69
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-21.55
|
-25.12
|
18.64
|
-21.55
|
3.03
|
|
Peer Median
|
2.14
|
--
|
--
|
--
|
--
|
EBIT Margin
-29.39
Lower than Peers by 36.45
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-29.39
|
-30.15
|
-76.05
|
-16.66
|
0.59
|
|
Peer Median
|
7.06
|
--
|
--
|
--
|
--
|
Net Margin
-76.73
Lower than Peers by 79.89
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-76.73
|
-81.73
|
65.32
|
-21.75
|
2.91
|
|
Peer Median
|
3.16
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-50.44
Lower than Peers by 60.28
Year on year growth in net sales
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-50.44
|
0.03
|
-0.71
|
-0.09
|
0.55
|
|
Peer Median
|
9.83
|
--
|
--
|
--
|
--
|
EBIT Growth
-17.34
Lower than Peers by 33.54
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-17.34
|
59.28
|
-32.46
|
-2,677.17
|
102.28
|
|
Peer Median
|
16.21
|
--
|
--
|
--
|
--
|
Net Profit Growth
-377.72
Lower than Peers by 394.90
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-377.72
|
-228.54
|
189.86
|
-759.21
|
110.11
|
|
Peer Median
|
17.18
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.00
Lower than Peers by 0.38
Total debt / Net worth
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
0.00
|
0.06
|
0.09
|
0.38
|
0.33
|
|
Peer Median
|
0.38
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.02
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
0.02
|
0.02
|
0.02
|
0.02
|
0.10
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.84
Higher than Peers by 1.36
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
2.84
|
2.82
|
2.46
|
2.21
|
2.71
|
|
Peer Median
|
1.48
|
--
|
--
|
--
|
--
|
Quick Ratio
2.50
Higher than Peers by 1.12
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
2.50
|
2.55
|
2.26
|
1.59
|
2.22
|
|
Peer Median
|
1.38
|
--
|
--
|
--
|
--
|
Interest Coverage
-38.80
Lower than Peers by 43.12
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-38.80
|
-48.83
|
-16.89
|
-112.16
|
86.50
|
|
Peer Median
|
4.32
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
15.68
Higher than Peers by 2.56
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
15.68
|
12.50
|
15.48
|
4.45
|
8.66
|
|
Peer Median
|
13.12
|
--
|
--
|
--
|
--
|
Asset Turnover
0.28
Lower than Peers by 0.50
Sales / Average Total Assets
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
0.28
|
0.31
|
0.29
|
1.02
|
1.04
|
|
Peer Median
|
0.78
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
--
|
50.35
|
56.27
|
25.52
|
30.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
--
|
156.15
|
218.74
|
78.72
|
58.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
--
|
52.34
|
68.29
|
33.21
|
47.33
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
--
|
154.16
|
206.71
|
71.03
|
40.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
0.65
Lower than Peers by 2.89
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
0.65
|
--
|
--
|
--
|
--
|
|
Peer Median
|
3.54
|
--
|
--
|
--
|
--
|
Dividend Yield
125.00
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
125.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-3.27
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
-3.27
|
6.45
|
3.60
|
0.07
|
-6.23
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
16
Lower than Peers by 354
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Jul-24
|
Jul-23
|
Jul-22
|
Jul-21
|
|---|---|---|---|---|---|
|
Enzo Biochem Inc. ($0.01 Par Value) (ENZ)
|
16
|
--
|
--
|
--
|
--
|
|
Peer Median
|
371
|
--
|
--
|
--
|
--
|